Cited by 69Nanoparticle-Based Drug DeliveryHIV/AIDS drug development and treatmentHIV Research and Treatment

The DOI matches its Crossref record; the references it cites are not checked yet.

Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood

Open access

Abstract

Insufficient HIV drug levels in lymph nodes have been linked to viral persistence. To overcome lymphatic drug insufficiency, we developed and evaluated in primates a lipid-drug nanoparticle containing lopinavir, ritonavir, and tenofovir. These nanoparticles produced over 50-fold higher intracellular lopinavir, ritonavir and tenofovir concentrations in lymph nodes compared to free drug. Plasma and intracellular drug levels in blood were enhanced and sustained for 7 days after a single subcutaneous dose, exceeding that achievable with current oral therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qad.0000000000000421

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Lipid-based nanoparticles loaded with three to four antiretrovirals including lopinavir, ritonavir and tenofovir enhanced circulation times of the antiretrovirals and increased their uptake into mononuclear cells in peripheral blood and lymph nodes of macaques.

    “Nanoencapsulation enhanced circulation times of the antiretrovirals and increased their uptake into the mononuclear cells in peripheral blood and lymph nodes of macaques.”

    From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [96]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 17 · Cited by 69

Metadata

Authors
Freeling, J. P., Koehn, J., Shu, C., Sun, J., & Ho, R. J. Y.
Affiliations
University of Washington (US)
Corresponding author
Ho, Rodney J.Y.
Venue
AIDS
Published
2014-11-13
Volume
28
Issue
17
Pages
2625-2627
ISSN
0269-9370 (ISSN-L)
OpenAlex
W2330655155
Cited by
69
References
17
Citations by year
2026: 3 · 2025: 2 · 2024: 7 · 2023: 5 · 2022: 2 · 2021: 5 · 2020: 12 · 2019: 2 · 2018: 11 · 2017: 5 · 2016: 8 · 2015: 6 · 2014: 1
FWCI
2.52
Type
journal article
Language
en
Open access
Locations
  • AIDS (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (UL1TR000423)
  • Center for AIDS Research, University of Alabama at Birmingham
  • National Institute of Allergy and Infectious Diseases (R01AI077390, AI-077390, R01AI052663)
  • National Center for Research Resources (RR00166, RR025014, UL1RR025014, P51RR000166)
  • National Center for Advancing Translational Sciences
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords
HIV, lopinavir, ritonavir, tenofovir, lymph nodes, intracellular drug concentration, viral persistence, subcutaneous dosing, nonhuman primate model
MeSH terms
Tenofovir, Adenine, Animals, Blood Cells, Drug Carriers, Drug Combinations, Lymph Nodes, Macaca nemestrina, Plasma, Anti-HIV Agents, Ritonavir, Nanoparticles, Lopinavir, Organophosphonates

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review